Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05735197
What this trial is testing

Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseasesBone Diseases, Metabolic
Mansoura University 100
Post-approval studies (Phase 4)UnknownNCT04796428
What this trial is testing

GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial

Who this might be right for
Diabetes Mellitus, Type 2
Center for Outcomes Research and Clinical Epidemiology, Italy 1,167
Large-scale testing (Phase 3)Active Not RecruitingNCT06260722
What this trial is testing

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 1,250
Large-scale testing (Phase 3)UnknownNCT06535529
What this trial is testing

Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

Who this might be right for
Acute Decompensated Heart Failure
Helwan University 60
Not applicableActive Not RecruitingNCT05944432
What this trial is testing

CGM Use in Adults With Type 2 Diabetes on Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Abbott Diabetes Care 469
Large-scale testing (Phase 3)Looking for participantsNCT05879276
What this trial is testing

Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.

Who this might be right for
Cardiogenic Shock
Central Hospital, Nancy, France 164
Large-scale testing (Phase 3)Looking for participantsNCT06142474
What this trial is testing

SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning

Who this might be right for
Heart Failure AcuteVentilator Lung
National Taiwan University Hospital 450
Large-scale testing (Phase 3)Study completedNCT01413204
What this trial is testing

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 272
Not applicableStudy completedNCT05359341
What this trial is testing

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Who this might be right for
Diabete Type 2
Sadat City University 175
Not applicableEnded earlyNCT06094231
What this trial is testing

Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study

Who this might be right for
Chronic Kidney DiseasesDiabetes MellitusPreDiabetes+1 more
Department of Nephrology Clinic Ottakring Vienna 4
Early research (Phase 1)Study completedNCT05013502
What this trial is testing

Empagliflozin in Diuretic Refractory Ascites

Who this might be right for
Liver CirrhosisCirrhosisAscites+2 more
Stanford University 14
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Not applicableStudy completedNCT03717207
What this trial is testing

Cardiac Autonomic Dysfunction in Diabetics Patients With Syncope

Who this might be right for
Syncope, Vasovagal
University of Campania Luigi Vanvitelli 242
Large-scale testing (Phase 3)Study completedNCT02897219
What this trial is testing

ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Astellas Pharma Inc 175
Not applicableLooking for participantsNCT07601867
What this trial is testing

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting

Who this might be right for
Heart FailureCoronary Arterial Disease
Pyatigorsk City Clinical Hospital Number 1 72
Post-approval studies (Phase 4)Not Yet RecruitingNCT06858436
What this trial is testing

SGLT2 Inhibitor Utilization Re-perfusion Therapy

Who this might be right for
Acute Ischemic Stroke From Large Vessel Occlusion
Taichung Veterans General Hospital 150
Not applicableUnknownNCT06326528
What this trial is testing

SGLT2 Inhibitors and Perioperative Period

Who this might be right for
Perioperative Complication
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03867487
What this trial is testing

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD
Justin Ryder 40
Post-approval studies (Phase 4)Ended earlyNCT05139914
What this trial is testing

Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Endothelial Dysfunction
Boston University 4
Next Page